|
Market Closed -
Nasdaq
16:00:00 2026-08-27 EDT
|
5-day change | 1st Jan Change | ||
| 807.71 USD | -0.87% |
|
-2.29% | +4.64% |
| 08-27 | AstraZeneca-Amgen asthma drug succeeds in late-stage oesophagus disease trial | RE |
| 08-25 | Veeva Systems Secures Biogen, Regeneron Pharmaceuticals as New Vault CRM Clients | MT |
Chart: Technical Analysis
Stock exchange
Nasdaq
REGN 807.71 $
-0.87%
620M
$
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
Nasdaq
| REGN | 807.71USD | -0.87% | 620M $ | |
CBOE
| REGN | 807.44USD | -0.92% | 13.49M $ | |
|
Tradegate
| RGO | 693.30EUR | -0.87% | 112K € | |
|
Boerse Muenchen
| RGO | 694.10EUR | -0.91% | 84.68K € | |
|
Xetra
| RGO | 699.10EUR | -0.38% | 22.37K € | |
|
Mexican S.E.
| REGN * | 14,010.00MXN | -1.05% | 182K $ | |
|
Börse Stuttgart
| RGO | 694.10EUR | -1.11% | 8.33K € | |
|
London S.E.
| 0R2M | 761.97USD | +15.48% | 7.62K $ | |
|
Deutsche Boerse AG
| RGO | 694.10EUR | -2.25% | 0 € | |
|
Wiener Boerse
| REGN | 706.60EUR | -2.00% | 0 € | |
|
Borsa Italiana
| 1REGN | 699.80EUR | -0.34% | 0 € | |
|
Lima
| REGNUS | 805.00USD | 0.00% | 0 $ | |
Sao Paulo
| REGN34 | 69.75BRL | +31.24% | 1.46K R$ |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bullish | Bullish |
| Resistance | 840.84 | 840.84 | 834.04 |
| Spread/Res. | -3.94% | -3.94% | -3.16% |
| Spread/Supp. | +9.49% | +13.32% | +16.65% |
| Support | 737.71 | 712.77 | 692.45 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- REGN Stock
- Charts Regeneron Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions
